BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Nov 27, 2025; 17(11): 109989
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.109989
Table 1 Overview of included systematic reviews
Ref.
Year
No. of studies
Patients (RLR, LLR, OLR)
Study designs
Key focus
Safiejko et al[6]202483210 (530, 2680, N/A)1 prospective, 6 retrospective, 1 randomizedRLR vs LLR intraoperative/postoperative
Machairas et al[7]2021929 (29, N/A, N/A)Case seriesSimultaneous robotic resections
Mkabaah et al[9]2025136582 (268, 3333, 2981)2 RCTs, 1 prospective, 10 retrospectivesComparative outcomes of RLR, LLR, OLR
Ho et al[12]201319217 (142, 43, 32)10 case series, 2 comparative, 7 case reportsEarly RLR adoption and complications
McGuirk et al[13]2021828 (28, N/A, N/A)Case seriesTechnical feasibility of RLR
Table 2 Conversion rates
Ref.
Year
RLR conversion rate
LLR conversion rate
OLR conversion rate
Statistical comparison
Safiejko et al[6]20246.7% (NR)12.4% (NR)NRLLR vs RLR: OR = 2.18, 95%CI: 1.46-3.24
Machairas et al[7]20210% (0/29)NRNRNR
Mkabaah et al[9]20254.7% (10/214)10.4% (328/3166)NRLLR vs RLR: OR = 27.50, 95%CI: 7.73-97.48
Ho et al[12]120134.6% (10/217)NRNRNR
McGuirk et al[13]20210% (0/28)NRNRNR
Table 3 Perioperative morbidity and mortality
Ref.
30-day mortality
90-day mortality
Postoperative complications
Safiejko et al[6]
    RLR0.5% (2/372); RLR vs LLR: OR = 1.23, 95%CI: 0.32-4.830.0% (0/178); RLR vs LLR: OR = 1.78, 95%CI: 0.23-14.0321.9% (106/482); RLR vs LLR: OR = 1.04, 95%CI: 0.81-1.32
    LLR0.7% (13/1931)1.3% (10/789)22.4% (404/1806)
Machairas et al[7]0% (0/29)0% (0/29)37.9% (11/29)
Mkabaah et al[9]
    RLR0.7% (2/268); RLR vs OLR: OR = 1.24, 95%CI: 0.24-6.360.6% (1/179); RLR vs OLR: OR = 0.45, 95%CI: 0.07-3.0323.6% (45/191); RLR vs OLR: OR = 0.52, 95%CI: 0.32-0.86
    LLR0.3% (5/1530); LLR vs OLR: OR = 1.01, 95%CI: 0.29-3.580.3% (1/292); LLR vs OLR: OR = 0.64, 95%CI: 0.08-5.2416.6% (113/678); LLR vs OLR: OR = 0.50, 95%CI: 0.37-0.68
    OLR0.7% (6/862)1.4% (4/296)26.4% (262/992)
Ho et al[12]0% (0/217)0% (0/217)20.3% (48/236)
McGuirk et al[13]0% (0/28)2.8% (1/28)28.6% (8/28)
Table 4 Oncological outcomes
Ref.
R0 resection rate
1-year OS
3-year OS
5-year OS
Key oncological findings
Safiejko et al[6]NR81.8% (RLR) vs 91.8% (LLR)47.7% (RLR) vs 65.9% (LLR)NRTrend favoring LLR (NS)
Machairas et al[7]100% (29/29)NRNR75.2% (single study)All R0 resections
Mkabaah et al[9]
RLR82.1% (202/246)100% (12/12)41.7% (5/12)NRNo significant differences between approaches
LLR84.6% (2501/2957)93.0% (213/229)69.4% (159/229)53.1% (191/360)
OLR87.7% (2277/2597)96.4% (321/333)69.3% (231/333)60.8% (477/785)
Ho et al[12]NRNRNRNRMixed malignancies included
McGuirk et al[13]100% (28/28)NRNRNRMargin status reported for all cases1
Table 5 Operative and postoperative metrics
Ref.
Operating time (min)
Blood loss (mL)
Hospital stay (d)
Key findings
Safiejko et al[6]247.9 (RLR) vs 272.9 (LLR)190.8 (RLR) vs 294.3 (LLR)5.8 (RLR) vs 5.6 (LLR)RLR reduced blood loss vs LLR (P < 0.001)
Machairas et al[7]399.5 (median)274 (median)7 (median)Simultaneous resections
Mkabaah et al[9]
    RLR304.1266.86.2RLR reduced blood loss vs OLR (P < 0.001)
    LLR191.8283.96.7
    OLR204.3413.812.9
Ho et al12]200-507 (range)50-660 (range)5.5-11.7 (range)Early RLR experience
McGuirk et al[13]420.3275.68.6Single-arm (no comparator)
Table 6 Methodological quality (Assessment of Multiple Systematic Reviews 2 assessment)
Ref.
Confidence rating
Key strengths
Key limitations
Safiejko et al[6]ModerateDirect RLR vs LLR comparisonRetrospective dominance, no RCTs
Machairas et al[7]LowFocus on SRARSmall cohort, no comparator group
Mkabaah et al[9]HighLarge sample, subgroup analysesHeterogeneity in study designs
Ho et al[12]LowEarly RLR adoption dataOutdated, mixed malignancies included
McGuirk et al[13]LowDetailed technical insightsSmall sample, case series bias